• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Geron Announces
Collaboration with Janssen

Click here for important information

 

Geron News

2.26.2015

Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2014 Financial Results and Recent Events

Read More

2.2.2015

Geron to Present at the 17th Annual BIO CEO & Investor Conference

Read More

12.16.2014

Geron Announces Early HSR Clearance for Global Strategic Collaboration with Janssen

Read More

 

Events

02.09.2015

Geron Presents at the 17th Annual BIO CEO & Investor Conference

Listen to Webcast

Download Presentation

12.08.2014

Geron Hosts Analyst and Investor Meeting

Listen to Webcast

Download Presentation

12.03.2014

Geron Presents at the Piper Jaffray Healthcare Conference

Listen to Webcast